Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ADMEcell is a biotechnology company specializing in the provision of innovative tools and services for ADME (Absorption, Distribution, Metabolism, and Excretion) profiling. The company is widely recognized for its ready-to-use cell-based assay kits, which utilize pre-plated and differentiated cell monolayers like Caco-2 and MDCK to assess drug permeability and transporter interactions. These products enable pharmaceutical and biotechnology researchers to conduct critical drug-drug interaction (DDI) studies and human intestinal absorption predictions with significantly reduced preparation time. ADMEcell's portfolio focuses on key regulatory-relevant transporters, including P-glycoprotein and BCRP. By streamlining the cell culture process, the company helps accelerate the lead optimization and preclinical stages of drug discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ADMEcell.